Literature DB >> 25973234

Surgical specimen histology revealed inadequacy of conventional transbronchial needle aspiration sample in the diagnosis of adenosquamous lung carcinoma.

Jing Chen1, Ya-Dong Gao1, Yan Cao1, Jiong Yang1, Guang-Wei Luo1.   

Abstract

OBJECTIVE: We retrospectively reviewed the accuracy of conventional transbronchial needle aspiration (cTBNA) in the subtyping of lesions located in or around central airways by comparing the histological diagnosis based on TBNA and surgical specimens.
MATERIALS AND METHODS: cTBNA was conducted in consecutive patients with lesions located in or around the central airways (trachea, left and right primary bronchi, hilar and mediastinal masses or lymph nodes) between October 2012 and May 2014 in Wuhan No. 1 Hospital. The aspirated specimens in all patients were performed cytological and/or histopathological examination. Of these patients, some were subjected to surgical resection and histopathological examination was performed by the Department of Pathology. In the patients with gross specimens, the final diagnosis was established based on histopathological results from these specimens.
RESULTS: In 63 patients diagnosed with cTBNA for the lesions located in or around the central airways, 23 patients with a diagnosis of lung cancer or atypical hyperplasia underwent surgery. The final diagnosis based on histopathology of surgery specimen was lung cancer in 22 patients [3 small cell lung cancer (SCLC), 9 squamous cell carcinoma (SCC), 5 adenocarcinoma (ADC), 4 adenosquamous carcinoma (ADS) and 1 neuroendocrine carcinoma], and inflammatory pseudotumor in 1 patient. The overall diagnostic yield of cTBNA for lung cancer was 95.7% (22/23), but the accuracy for histological typing of lung cancer is only 63.6% (14/22), for adenosquamous lung carcinoma was only 25% (1/4).
CONCLUSIONS: cTBNA is a safe and effective procedure that can be used for the diagnosis of central lung cancer. However, the accuracy of TBNA for the histological classification of lung cancer is relatively low, especially for adenosquamous lung carcinoma.

Entities:  

Keywords:  Transbronchial needle aspiration (TBNA); adenosquamous lung carcinoma; histology; lung cancer

Year:  2015        PMID: 25973234      PMCID: PMC4419313          DOI: 10.3978/j.issn.2072-1439.2015.04.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

1.  Learning curve of conventional transbronchial needle aspiration in pulmonologists experienced in bronchoscopy.

Authors:  Frank H W Hermens; Gijs J M Limonard; René Termeer; Willem van den Berg; Frank J Visser; Bernard E A Hol; Julius P Janssen
Journal:  Respiration       Date:  2007-12-19       Impact factor: 3.580

Review 2.  Transbronchial needle aspiration: a systematic review on predictors of a successful aspirate.

Authors:  Martina Bonifazi; Lina Zuccatosta; Rocco Trisolini; Lorenzo Moja; Stefano Gasparini
Journal:  Respiration       Date:  2013-06-29       Impact factor: 3.580

3.  Rapid on-site pathologic evaluation does not increase the efficacy of endobronchial ultrasonographic biopsy for mediastinal staging.

Authors:  Mark Joseph; Tyler Jones; Yasmin Lutterbie; Susan J Maygarden; Richard H Feins; Benjamin E Haithcock; Nirmal K Veeramachaneni
Journal:  Ann Thorac Surg       Date:  2013-05-31       Impact factor: 4.330

4.  ALK-rearranged adenosquamous lung cancer presenting as squamous cell carcinoma: a potential challenge to histologic type triaging of NSCLC biopsies for molecular studies.

Authors:  Konstantin H Dragnev; Gerald Gehr; Vincent A Memoli; Laura J Tafe
Journal:  Clin Lung Cancer       Date:  2014-01-18       Impact factor: 4.785

5.  A prospective study of conventional transbronchial needle aspiration: performance and cost utility.

Authors:  A R L Medford; S Agrawal; C M Free; J A Bennett
Journal:  Respiration       Date:  2010-01-21       Impact factor: 3.580

Review 6.  Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?

Authors:  Kristell Bastide; Nicolas Ugolin; Céline Levalois; Jean-François Bernaudin; Sylvie Chevillard
Journal:  Lung Cancer       Date:  2009-12-08       Impact factor: 5.705

7.  Transbronchial needle aspiration: initial experience in routine diagnostic bronchoscopy.

Authors:  Kay-Leong Khoo; Gerald S W Chua; Amartya Mukhopadhyay; T K Lim
Journal:  Respir Med       Date:  2003-11       Impact factor: 3.415

8.  Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma.

Authors:  Zhengbo Song; Baochai Lin; Lan Shao; Yiping Zhang
Journal:  J Chin Med Assoc       Date:  2013-06-13       Impact factor: 2.743

9.  Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.

Authors:  Toshihiro Shiozawa; Genichiro Ishii; Koichi Goto; Kanji Nagai; Sachiyo Mimaki; Shotaro Ono; Seiji Niho; Satoshi Fujii; Yuichiro Ohe; Katsuya Tsuchihara; Atsushi Ochiai
Journal:  Pathol Int       Date:  2013-02-21       Impact factor: 2.534

10.  Transbronchial needle aspiration "by the books".

Authors:  Elif Kupeli; Leyla Memis; Tugce S Ozdemirel; Gaye Ulubay; Sule Akcay; Fusun O Eyuboglu
Journal:  Ann Thorac Med       Date:  2011-04       Impact factor: 2.219

View more
  6 in total

Review 1.  International association for the study of lung cancer map, Wang lymph node map and rapid on-site evaluation in transbronchial needle aspiration.

Authors:  Qing-Hua Liu; Sixto Arias; Ko-Pen Wang
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience.

Authors:  Chao Zhang; Haitang Yang; Heng Zhao; Baoping Lang; Xiangdong Yu; Peng Xiao; Xiao Zhang
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

3.  Analysis of unexpected small cell lung cancer following surgery as the primary treatment.

Authors:  Haitang Yang; Jianlin Xu; Feng Yao; Shunqing Liang; Heng Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-20       Impact factor: 4.553

4.  Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection.

Authors:  Liwen Fan; Haitang Yang; Feng Yao; Yang Zhao; Haiyong Gu; Ke Han; Heng Zhao
Journal:  Onco Targets Ther       Date:  2017-01-06       Impact factor: 4.147

5.  Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma.

Authors:  Chao Zhang; Haitang Yang; Baoping Lang; Xiangdong Yu; Peng Xiao; Dian Zhang; Liwen Fan; Xiao Zhang
Journal:  Cancer Manag Res       Date:  2018-08-02       Impact factor: 3.989

6.  Does surgically resected small-cell lung cancer without lymph node involvement benefit from prophylactic cranial irradiation?

Authors:  Yuqing Lou; Runbo Zhong; Jianlin Xu; Rong Qiao; Jiajun Teng; Yanwei Zhang; Xueyan Zhang; Tianqing Chu; Hua Zhong; Baohui Han
Journal:  Thorac Cancer       Date:  2020-03-06       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.